Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

Publisher： Karger

E-ISSN： 2296-5262|25|5|426-430

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.25, Iss.5, 2002-11, pp. : 426-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-09 ,pp. : 334-339

Karger

Access to resources Recommend Favorite

Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 476-480

Karger

Access to resources Recommend Favorite

Oxaliplatin/5‐fluorouracil‐based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 334-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

5-Fluorouracil Leucovorin and Oxaliplatin (FOLFOX) in the Treatment of Metastatic Colon Cancer with Severe Liver Dysfunction

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 222-224

Karger

Access to resources Recommend Favorite